Pharming B.V.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Pharming B.V.
Live alerts from global media, monitored by Business Radar
2025-01-16 (iex.nl)
Fundlogic sells almost its entire stake in Pharming
Fundlogic SAS has almost completely sold its interest in Pharming Group. This emerged on Thursday from a notification in the context of the Financial Supervision Act, dated January 14, 2025.
Read more
2025-01-16 (iex.nl)
Fundlogic sells almost its entire stake in Pharming
Fundlogic SAS has almost completely sold its interest in Pharming Group. This emerged on Thursday from a notification in the context of the Financial Supervision Act, dated January 14, 2025.
Read more
2024-09-26 (iex.nl)
British green light for Joenja from Pharming
Pharming has received market approval from the British regulator MHRA for the sale of its drug Joenja for the treatment of APDS, a rare and progressive primary immune system disorder. That made the biopharmaceutical bed...
Read more
2024-09-26 (iex.nl)
British green light for Joenja from Pharming
Pharming has received market approval from the British regulator MHRA for the sale of its drug Joenja for the treatment of APDS, a rare and progressive primary immune system disorder. That made the biopharmaceutical bed...
Read more